LIMN
Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
LIMN Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-31 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-04
Form 8-K - Current report
Key Events
2026-03-04 · Key Events
Form 8-K - Current report
2026-02-20
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-20 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-18
Form 8-K - Current report
Key Events
2026-02-18 · Key Events
Form 8-K - Current report
2026-02-18
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-02-18 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-02-17
Form EFFECT - Notice of Effectiveness
2026-02-17 ·
Form EFFECT - Notice of Effectiveness
2026-02-11
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-11 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-09
Form 8-K - Current report
Key Events
2026-02-09 · Key Events
Form 8-K - Current report
2026-01-26
Form 8-K - Current report
Key Events
2026-01-26 · Key Events
Form 8-K - Current report
2025-12-31
Form DRS - Draft Registration Statement
2025-12-31 ·
Form DRS - Draft Registration Statement
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
